RESULTS: Older Mexican Americans with diabetesin 200412005 were more likelyto be taking 2 or more oral diabetes medications than were those in the 1993/1994 cohort; most of the drugs taken by the 200412005 cohort were the newly introduced oral diabetes medications. Use of insulin as sole diabetestherapy decreased from 20.3% in the 1993/1994 cohort to 7.5% in the 2004/2005 cohort. The 2004/2005 cohort reported longer diabetes duration and higher prevalence of obesity and hypertension; they were also more likely than the 1993/1994 cohort to have more geriatric syndromes: pain, arthrit is, incontinence. and self-reported activities of daily living disability. No significant differencesexist between the 2 cohorts in objective measuresof cognitive and physical function. CONCLUSIONS: Older Mexican Americans with diabetes in 200412005 used more of the newer diabetes medications and less insulin compared to the 1993/1994 cohort. The prevalencerates of geriatric syndromeswere higher in the 200412005 cohort. Our findings suggest that screening for and treating comorbid geriatric syndromes is increasingly important lor optimal geriatric diabetes care.
D iabetes is the seventh leadingcause of death in theUS and its prevalence is expected to increase dramatically amongolderadults in the coming years.' In particular, Mexican Americans, a fastgrowing segment of the US population, are disproportionately affected by type 2 diabetes. Recent research estimates the prevalence of diabetes among Mexican Americans aged 75 years and olderto be around 37% in 2004/2005, a rate higher thantheprevalence of 15.4% among non-Hispanic white adults of equivalent age. l ,2 Also, MexicanAmericans with diabetes havehighrates of diabetes-related complications, in partdue to multiple comorbidities(eg,hypertension) and suboptimal adherence to diabetes medication." National trends show that the treatment prescribed to patients with type 2 diabetes has changed over the past decade with the advent of new medications and the introduction of new practice recommendations for older popula-tionsP Data from the National Disease and Therapeutic Index show a declining use of insulin from 38% to 25%between 1994 and 2007. 6 Concomitantly, new Author informationprovided at end of text. BACKGROUND: New diabetes medications introduced over the last decade have led to changes in diabetes treatmentrecommendations for the increasingnumber of elderly patients with diabetes. It is, however, not clear whether these changes are accompanied by changes in prevalence of comorbid geriatric syndromes. (5) were includedin the analyses. Medicationuse and geriatric syndromesprevalence rates were estimated and compared using descriptive and univariate statistics for continuousvariables and contingencytables(Z2) for categorical variables. oral antidiabeties therapies have been introduced into the US market. The American Diabetes Association (ADA) also recommends that physicians optimize the treatment of conditions commonly associated with diabetes (eg, hypertension and hyperlipidemia). These treatment recommendations, alongwith more medication options, may help reduce diabetes-related complications, potentially leading to increased quality of life. However,use of medications in older patients with diabetes to achieve target goals of glycemia,lipids, and blood pressure may not always lead to reducedcardiovascular events (eg, stroke and myocardial infarction) or increased quality of life unless adequate attention is paid to optimal management of specific geriatricsyndromes.v'?
Geriatric syndromes are a group of conditions (eg, urinary incontinence, depression, cognitive impairment, pain, and functional disability) witha common multifactorial etiology often seen in frail olderadults,"These conditions are highly prevalent in persons with diabetes,":" A 7-year prospective cohort study of initially nondisabled Mexican Americans aged65 years andolder(N == 1835) showed that participants with diabetes were more likely to report anylimitation in lower bodyactivities of daily living (ADL) function (HR 2.05; 95% CI 1.58 to 2.67), mobility tasks (HR 1.69; 95% CI 1.39 to 2.04), and 8-foot walk (HR 1.46; 95% CI 1.15 to 1.85) compared to those withno history of diabetes." These findings remained significant evenafter controlling for age,sex,medical conditions, vision function, cognition, and obesity at baseline. Otherresearchers have alsoshownthat elderly persons with diabetes have a higherrate of depressive symptoms, disability, incontinence, vision impairment, and healthserviceuse than those without diabetes." However, little is known about changes in diabetes treatments over time and whether such changes are accompanied by changes in the prevalenceof geriatricsyndromes over time in Mexican Americans aged 75 years and older.
To addressthis gap in knowledge, this study examined the trends in use of diabetes medications and the prevalenceof geriatric syndromes from 1993/1994 to 2004/2005 in Mexican Americans aged 75 years and older, usingdata from 2 samples of subjects participating in the Hispanic Established Population for the Epidemiologic Studyof the Elderly (Hispanic EPESE).This study builds on previous research describing older Mexican Americans with diabetes. s ,!3. 16 With the advent of newer antidiabetes medications over the last decade and increasing publiceducation aboutensuring gooddiabetes control, we hypothesized that the prevalence of geriatric syndromes would be lower in the 2004/2005 cohorts than in the 1993/1994 cohorts of Mexican American elders with diabetes. Our hypothesis was derived from the well-known diabetes-associated complications of stroke,neuropathy (painful sensory, autonomic, and motor subtype),and peripheral artery disease (painfrom ischemic limbsand amputations); thesecompli-cations may indirectly influence the onset and progression of geriatric syndrome conditions (eg, motordisability, impaired cognition, pain,and urinary incontinence).
Methods

SAMPLE
The sample for this study was obtained from the Hispanic EPESE, a longitudinal community-based study of older Mexican Americans residing in the southwestern US (Texas, California, Arizona, Colorado, and New Mexico). The baseline sample interviewed in 1993/1994 included 3050 Mexican Americans aged 65 years and older selected through a multistage area probability sampling procedure. This sample selection methodology ensured that results would be generalizable to approximately 500,000 older Mexican Americans. Details of the sampling strategy are described elsewhere.l? In 1993/1994, 1332subjects were aged 75 years and older. In 2004/2005 a new sample of Mexican Americans aged 75 years and older (n == 902) was added to the study using a similar sampling strategy. In this study,the sample includedsubjects aged 75 years and older with diabetes in 1993/1994 (n == 284) and in the new cohort added in 2004/2005 (n == 324).In the 1993/1994 cohortthere was medication information on 196 subjects and, in 2004/2005, on 284 subjects. Those without medication data were significantly more likely to be older and have instrumental ADL (IADL) disabilities. The University of Texas Medical Branch Institutional Review Board on human protection and research ethicsapproved the study.
MEASURES
Subjects were codedas havingdiabetes if in 1993/1994 and 2004/2005 they reported that they had been told by a physician that they had diabetes, glucose in their urine, high blood glucose levels, or if they were found to be on any antidiabeties drugsupon inspection of the medications they hadtakenin the 2 weeks priorto the interview.
MEDICATIONS
Diabetes treatment wasdetermined by categorizing each subject's medications. Medications were ascertained by asking each respondentto show the interviewerall drugs taken in the 2 weeks prior to the interview. Subjectswere considered to be on diabetes treatment if oral antidiabetes medications and/or insulin were found duringthe medications inspection process.Antidiabetes drug treatment was classified into 4 groups: oral antidiabetes medication only, insulinonly, taking both oral antidiabetes medication and insulin, and receiving no treatment. The antidiabeties medications werealso classified by drug class.Drug classes in-
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The AnnalsofPharmacotherapy • 2010 September, Volume 44 • 1377 c1uded sulfonylureas only, biguanides, multiple combinations of medications, and others. The combination medication category included single-pill formulations containing 2 medications as well as multiple medications taken in more than I pill. The other category included meglitinide derivatives and thiazolidinediones. These medications were combined into I category due to the small number of respondents taking them. Lastly, patients not on any treatment for their diabetes were classified as receiving no treatment.
BLOODPRESSURE MEASUREMENTS AND USE OF
ANGIOTENSIN INHIBITORS
Blood pressure was measured by average standing blood pressure reading and dichotomized as <130/80 and 130/S0 mm Hg. Additionally, the participants were also assessed for the use of angiotensin inhibitors (eg, angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists). Subjects were considered to be on angiotensin inhibitors if angiotensin inhibitor medications were found during the medication inspection process. We included assessment of blood pressure goal <130/S0 mm Hg and use of angiotensin inhibitors because they are practice recommendations by the ADA.7Optimal blood pressure control and angiotensin inhibitor use have been shown to reduce the risk of diabetes-related kidney damage.'
GERIATRIC SYNDROMES
Geriatric syndromes assessed in this study were cognitive function, presence of pain, arthritis, incontinence, and physicalfunction. Cognitive function was dichotomizedas a score of <21 (impaired or poor cognition) and ;::21 (normal or good cognition) using the Mini-Mental State Examination. 18 .;w The presence of pain was measured with the question, "In the past month, did you notice any pain or discomfort when you stood or walked?" Answers were coded as "1" for having pain and "0" for no pain, during data analysis. Subjects were coded as having arthritis if they indicated that a physician or health-care professional told them they had arthritis. The response to the question was coded as yes versus no. Incontinence was measured by a self-report question asking each subject, "How often do you have difficultyholding your urine until you can get to a toilet-never, hardly ever, some of the time, most of the time, or all of the time?" Incontinence was dichotomized into 2 groups: those who had difficulty some or most of the time versus the others. Physical function was measured by 2 self-report questions on. ADL and IADL. ADL disability was determined if a subject indicated needing help with one or more of the following: bathing, grooming, dressing, eating, transferring, or toilet-ing. IADL disability was determined by needing assistance with one or more of the following: using the telephone, driving,shopping,preparing meals, doing light housework, taking medicine, or handling money. Additionally, a measured assessment of physical function was included using the Performance Oriented Mobility Assessment (POMA). The POMA consists of standard measured assessments of standing, balance, and walking speed," The POMA total was categorized as 1-4,5-8, and 9-12. Additionally, balance, chair stands, and walking a normal pace were analyzed separately.
COVARIATES
Other covariates included in the analyses included age, sex, marital status, education, body mass index (BMI), self-reported hypertension,duration of diabetes,and health insurance coverage. Age was measured on a continuous scale. Sex was coded I for female and 0 for male. BMI was calculatedfrom measured height and weight and categorized into <25,25-29, and~30 kg/m'. Hypertension was determined through a self-reportquestion asking each subject, "Has a doctor ever told you that you have high blood pressure?" Health insurance was categorized into 4 groups: no insurance, Medicare only, Medicare and Medicaid, or private insuranceand Medicare.
STATISTICAL ANALYSIS
The descriptive characteristics of the sample were calculated as means and 95% confidence intervals for continuous variablesand proportionsfor categorical variables. All comparisonswere made using Rao-Scott"I: for categorical variables and t-test statistics for continuous variables. The prevalence of diabetes treatment and geriatric conditions was estimated in both cohorts using the Rao-Scott "I: test. SAS version 9.2 survey procedures software (SAS Inc., Cary,NC) was used to perform all analyses. Table 3 shows the prevalence of geriatric syndromes among the 2 cohorts. Subjects in the 2004/2005 cohort were more likely to have more geriatric syndromes, including pain, arthritis, and incontinence, than those in the 1993/1994 cohort. Additionally, self-reported ADL disability increased between the 2 time periods.
Results
The prevalence of pain nearly doubled between the 2 time periods, from 37.1% in 1993/1994 to 61. 
Discussion
We examined trends in antidiabetes medication use between 1993/1994 and 2004/2005 and whether these trends would be accompanied by changes in the prevalence of geriatric syndromes over the same period in older Mexican Americans with diabetes. Those in the 2004/2005 cohort were more likely to be taking 2 or more oral antidiabetes drugs than were those in the 1993/1994 cohort. The use of insulin as sole diabetes therapy was lower (7.5%) among the 2004/2005 cohort compared with the 1993/1994 cohort (20.3%). Sulfonylurea and insulin use decreased and metformin use increased in the new cohort. The 2004/2005 cohort reported longer diabetes duration and higher prevalence of obesity and hypertension. Subjects in the 2004/2005 cohort were also more likely than those in the 1993/1994 cohort to have geriatric syndrome conditions: pain, arthritis, incontinence, and self-reported ADL disability. No significant differences existed between the 2 cohorts in objective measures of cognitive and physical function.
The observation that conditions that make up the geriatric syndromes have increased in prevalence over 10 years is a surprising finding; we thought the exposure of the 2004/2005 cohort to newer (and presumably more effective) diabetes medications would translate to better health outcomes, as defined by lower rates of geriatric syndromes. Our findings of high rates of geriatric syndromes in seniors with diabetes are consistent with past research suggesting that current clinical guidelines may not always be adequate for frail older adults with diabetes.v-" Our findings of increased geriatric syndromes in the 2004/2005 This study provides insightinto the management of diabetes among very old Mexican Americans,filling a gap in "Unwe ighted frequenc ies and weighted percents. bAngiotens in-convert ing enzyme inhibitors and angiotensin receptor.antagon ists. <Included >1 drug combined in 1 pill and the use 01~pills. which include the combinations of sulfonylurea and metform in: metform in and thiazolidinediones ; sulfonylurea and thiazolid inediones ; comb ination drug and metform in ; and sulfonylurea. melformin. and thiazo lidinediones. dlncluded meglitinide derivative and thiazol idinedion es. 
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knowledge about trends in antidiabeties medication use and the prevalenceof geriatric syndromes in this population.Our findings suggest that quality of care indicators for diabetes in the very old should include prevention and management of comorbidgeriatric syndromes, in addition to the ADA-recommended guidelines of optimalglycemic, blood pressure, and lipid control.":" The standard ADA treatment guidelines suggest that persons with diabetes meet strict glycemic, lipid, and blood pressure control to prevent diabetes-related complications.In the face of the recently publisheddata from the New EnglandJournal of Medicines" adherenceto these guidelines may not necessarily decreasecardiovascular events and other complications,especially in frail elders with multiple comorbidities and limited life expectancy. Findings from our study and others 8 • 12 thus underscore the importance of incorporating management of geriatric syndromes as part of routinecare for elderly patients living withdiabetes. Delayingor preventingthe onset of the conditions that make up geriatric syndromeshas been shown to improve seniors' quality of life, preserve their ability to live independently, and delaynursing homeplacement.P" Considerations of presence of geriatric syndromes, quality of life,and lifeexpectancy areincreasingly important in evaluating quality of care for older patients,12,22 in addition to ADA-recommended indicators of diabetes control.Strict adherenceto ADA guidelines may paradoxically resultin unwanted outcomesin olderpatients withdiabetes. For example, in a 3.5year randomizedstudy (the ACCORD [Actionto Control Cardiovascular Risk in Diabetes Study Group) Trial) of 10,251 patientswith diabetes (mean age 62.2 years), those with tightly controlleddiabetes (median AIC 6.4%) were 22%(HR 112; 95%CI 1.01 to 1.46; p =0.04)morelikely to die compared to those with less tight control (A1C 7.0-7.9%),1.3 Patients in the tightcontrol groupalsoexperienced more hypoglycemic episodes and weight gain of over 10 kg. 23 Again,becauseof lack of blood data in our study, we cannotinvestigate the association between glycemic control andpresence of geriatric syndromes.
It is not clear how diabetes mightbe associated with increased riskof geriatric syndromes. The increase in BMI and longerduration of diabetes amongthe 2004/2005 cohortare potential explanations for the increased rate of geriatric syndromes we observedover time. Diabetesis known to alter neuromuscular functions as a resultof neuropathic and vasculopathic changes. IO • IJ ,24 Such alterations in function might over time lead to decreased mobility and ADL ability, poor bladder control, andhighriskof neuropathic pain. Subjects in the 2004/2005 cohort had a higher BMI than those in the 1993/1994 cohort. The increase in obesity andoverweight in thenewcohort might alsohavecontributed to thehigher rates of incontinence, pain,and arthritis, a finding consistent with pastresearch." In a cross-sectional study of 925communitydwelling elderly women aged 70 years andolder, obesity was independently associated with greater likelihood of reporting pain (OR 1.46; 95% CI 1.07 to 2.01) and urinary incontinence (OR 1.44; 95% CI 1.08 to 1.92).24 This increase in overweight! obesity in the 2004/2005 cohort suggeststhat clinicians should increase theirefforts in the management of obesity in elderly patients with diabetes; these efforts may have potential to decrease the occurrence of geriatric syndromes in thispopulation.
Another area needing moreeffortfromclinicians is optimal blood pressuremanagement. The resultsof our study showedthat,despite over 70% of subjects reporting having hypertension in 2004/2005, only30%reached thegoalblood pressure recommended by the ADA.Thisfinding suggests a needto develop and testmoreeffective and culturally appropriate ways to improvehypertension management in older MexicanAmericans withdiabetes. This population will be prime candidates for useof angiotensin inhibitors as first-line antihypertensive agents. The finding of poorbloodpressure control in this populationmay in part explain some of the previously reported increased riskof kidney problems in older Mexican Americans withdiabetes/
The limitations of our study include the use of self-report for diagnosis of diabetes rather than use of fasting plasmaglucose levels. However, self-reported diabetes has been found to be a highlyreliable measure. 15 • 28 Becauseof the absence of blood data in our study, we could not test the association between tightglycemic control as measured by AIC and increased risk of geriatric syndromes. Examining this association is an important area for future research.The lack of blood measurements in our study precludedtesting whetherthe increased prevalence of geriatric syndromes in the new cohort is related to high Ale level and diabetes duration. Finally,the prevalenceof geriatric syndromes reported in this study may have been influenced by the levelof awareness of the conditions. Awareness of disease was not a factorincluded in the survey.
In conclusion,older Mexican Americans with diabetes in 2004/2005 used more metforminand less sulfonylurea compared to the 1993/1994 cohorts. Use of insulin as the sole diabetes therapywas also lower in the 2004/2005 cohort. Subjects in the 2004/2005 cohorthad a higher prevalence of obesity and hypertension; they were also more likely than those in the 1993/1994 cohort to have more geriatric syndromes: pain, arthritis, incontinence, and selfreported ADL disability. Because of the higher BMI in the new cohort, it is possible that clinicians may be adjusting their practiceby prescribing more metforminand less sulfonylureas for those in the new cohortwho are overweight; metformin is associated with weight loss, while sulfonylureas tend to promote weight gain. For very old Mexican Americans with diabetes,our findings of increasing prevalence of comorbid geriatric syndromes suggest that preventing and managingthese comorbidities is increasingly important for optimal geriatric diabetes care.Any interven-
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The AnnalsofPharmacotherapy • 2010 September, Volume 44 • 1381 tion to manage these comorbidities(eg, drugs for impaired cognition) will require a consideration of the elderly patient's remaining life expectancy,the patient's preferences, evidence-based data for cost-effectiveness, and potential harms from polytherapy. Additional studies are needed to investigatepotential explanatory mechanisms (eg, increasing BMI) for the increasing prevalence of incontinence, ADL disability,and other geriatric syndromes in older patients with diabetes. Such studies might inform development and implementation of interventions to reduce the burdens of diabetes-related morbidityin the elderly. 
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EXTRACfO
TRANSFONIXl: Los nuevosmedicarnentos diabeticos que se han introducido durante la ultima decadahan producido cambios en las recomendaciones de tratamiento para un mimero mayorde pacientes ancianos con diabetes. Sinembargo, no estaclarosi estoscambioshan sidoacompaiiados por cambios en la prevalencia de co-morbilidad en los sfndromes geriatricos.
OBJETIVO: Determinar si loscambios en el tratarniento de la diabetes entre 1993/94 y 2004/05 fueron acompaiiados por cambios en la prevalencia de los sfndromes geriatricos en mexicano-americanos que tenian 75 aiiosy masde edad. Mtrooos: Se utiliz6 datosdel "Hispanic Established Population for the Epidemiologic Studyof the Elderly". Se incluy6 en el analisis participantes con diabetes que tenfan 75 aiios y mas de edaden 1993/94 (n = 284)Y2004105 (n = 324,se aiiadi6 un gruponuevoen 2004/05). Se estim6las tazas de prevalencia del usode medicamentos y de los sfndromes geriatricos y estasfueron comparadas usando estadistica descriptiva y univariable paralasvariables continuas y tablasde contingencia (X Z ) paralas variables categ6ricas.
RESULTADOS: Los mexicanos-americanos diabeticos de mayoredad estabanmas propensos en estartomando dos 0 mas medicamentos diabeticos oralesen 2004/05 que en eIcasodel grupode 1993/94. La mayorfa de estosmedicamentos diabeticos oralesfueron nuevos y de reciente introducci6n. EI usode la insulina comola terapia diabetica unicadisminuy6 a partirde un 203% en el grupode 1993/94 a un 75% en el grupode 2004/05. EIgrupode 2004/05 demostr6 teneruna duraci6n de diabetes mayory una prevalencia mayorde obesidad e hipertensi6n. Este grupotarnbien estabamaspropenso que, el de 1993-94 a tenermas sindromes geriatricos: dolor,artritis, incontinencia y discapacidad en autoinformes de actividades de la vidadiaria.No hubo diferencias significativas entrelos dos gruposen lasmedidas objetivas de la funci6n cognoscitiva y fisica. CONCLUSIONES: En 2004105.los mexicano-americanos diabeticos de mayoredadusaron mas de los medicamentos antidiabeticos nuevos y menosinsulina en comparaci6n aI grupode 1993/94. Los Indices de prevalencia de los sfndromes geriatricos fueron mas altosen el grupode 2004/05. Nuestros resultados sugieren que la investigaci6n yel tratarniento de la co-morbilidad de los sindromes geriatricos es cada vez mas importante en el cuido6ptimodel paciente geriatrico con diabetes. 
